Rewinding RX NAD+ prices
4 figures read September 2026.
Rewinding RX publishes a standing rate of $139 for NAD+, but never on a calendar month — it bills on a cycle of its own, and the difference is the whole reason this page prints the seller's own wording for it.
What Rewinding RX publishes
Rewinding RX publishes a standing rate, but never on a calendar month — it bills every 4 weeks, every 28 days, or across a multi-month term. Of the 11 sellers in this index that fall in the same bucket, that puts it with the 10% of the roster that publishes this shape of number rather than another one. A standing rate charged on a calendar month is the only figure this site treats as a monthly price, and 60 of the 106 sellers in this index — including this one — do not publish one.
The figure above is a standing rate, no cycle stated. This site never prints a price without that qualifier, on any surface, because the same number means a different thing depending on it — and in this corpus the same seller often prints several.
Every figure Rewinding RX publishes — 4 figures, read September 2026
| Figure | What it is | Cycle, in their words | Route | Dose | Read |
|---|---|---|---|---|---|
| $139.00 | standing rate | no cycle stated | not stated | 1000 mg (5 mL) | September 2026 |
| $149.00 | one-time | “One Time” | not stated | 1000 mg (5 mL) | September 2026 |
| $139seen twice, counted once | standing rate | “$139/month” | SubQ | 1,000mg | September 2026 |
| $149seen twice, counted once | one-time | “one-time” | SubQ | 1,000mg | September 2026 |
In Rewinding RX’s own words
- $139.00 standing rate
The page says: “Subscribe & Save $139.00 NAD+ 1000 mg (5 mL) Pause or cancel at anytime”
No billing cycle is stated beside this figure in visible text; the page only says every plan includes a 30-day supply. A DOM-only label reads 'Subscribe to Save 10% - Delivered Monthly'. This page never names the injection route; the seller's other page says subcutaneous.
Read from https://rewinding.com/product/nad on September 2026.
- $149.00 one-time
The page says: “One Time $149.00 NAD+ 1000 mg (5 mL) Free Express Shipping”
The non-subscription option on the same buy box.
Read from https://rewinding.com/product/nad on September 2026.
- $139 standing rate
The page says: “Monthly NAD+ subscription $139/month”
Tier named 'ONGOING VITALITY PROTOCOL', badged 'MOST POPULAR'. The FAQ states 'Our NAD+ formulation contains 200mg/ml. Our 5ml vial totals 1,000mg NAD+ in total.'
Read from https://rewinding.com/nad-plus on September 2026.
- $149 one-time
The page says: “One month of NAD+ $149one-time 1,000mg NAD+ (Prescription Strength)”
Tier named '30-DAY RESET'. The page renders the figure and the word run together as '$149one-time'.
Read from https://rewinding.com/nad-plus on September 2026.
Price disclosure score: 80 of 100
This scores what Rewinding RX publishes about its price, and nothing else. It is not a rating of the product, the clinic, the prescriber or the value — this site has read a price page, not used a product. Across all 106 sellers in the index the scores run from 6 to 100, with a median of 72. Rewinding RX sits 45 of 106.
| What is scored | What Rewinding RX publishes | Points |
|---|---|---|
| An exact figure | The headline figure is an exact charge for a defined purchase, not a floor and not a first-period rate. | 30of 30 |
| A stated cadence | No usable cadence. The page prints a number without saying what period it buys. | 0of 20 |
| Visible on the page | Every headline figure (1 figure) is printed where a reader can see it. | 20of 20 |
| A stated route | The seller states how the product is administered, in its own sentence. | 15of 15 |
| A stated dose | Every one of this seller's 4 figures states the dose it buys. | 15of 15 |
| Price disclosure score | This scores what the seller publishes about its price — not the product, the clinic, the prescriber or the value. | 80of 100 |
What Rewinding RX does not publish
Each of these is a count over what was actually read, not an impression. 4 figures were read from this seller, and every sentence below is measured against that number.
- None of the 4 figures read from this seller is a standing rate charged by the calendar month.
- 2 of 4 figures are the same price seen a second time — on a second capture or a second page — and are not counted twice anywhere on this site.
Figures visible to a reader on the seller’s page
4 of 4
Figures stating a dose
4 of 4
Figures that resolve to a usable price
4 of 4
Source: Counted over the 4 figures read from Rewinding RX’s own pages, September 2026. Each track is that figure count.
Where Rewinding RX sits
60 other sellers in this index also state a SubQ route. Ranked with them on price disclosure, Rewinding RX is 38 of 61. That is a statement about how completely each one publishes a price, and about nothing else — the figures behind those rows are different kinds of number and several of them state no dose, so they are not a like-for- like price comparison and this site does not present them as one.
Boards Rewinding RX appears on
The reading record
This site has read Rewinding RX once, in September 2026. A movement can only be shown between two readings taken here, so there is nothing to show yet — and a single reading is a fact about this site's record, never a statement that the seller held its price.
Figures are read from Rewinding RX’s own public pages and recorded with the date. What counts as a price, and why a “from” figure is recorded as a floor rather than a rate, is set out on the editorial policy page. Prices in this category move quietly, so the figure above is what the page said on September 2026 and not a promise about today.